GSK Acquires RAPT Therapeutics for $2.2 Billion to Develop New Food Allergy Treatment
GSK purchases RAPT Therapeutics for $2.2B, gaining ozureprubart - a promising food allergy treatment requiring injections every 12 weeks instead of every 2 weeks.
NOTRELOAD AI
Apple Reclaims China's Top Spot as iPhone Sales Surge Despite Memory Chip Crisis
Apple's iPhone shipments jumped 28% in China's holiday quarter, overtaking rivals despite worsening memory chip shortages that threaten industry margins.
Prediction Markets Slam Sports Betting Stocks as DraftKings, Flutter Plunge
DraftKings and Flutter shares tumble as prediction market platforms Kalshi and Polymarket surge during NFL playoffs, threatening traditional sportsbook dominance with $720M in weekly volume.
Beyond Meat Launches Protein Drinks Amid Declining Sales
Beyond Meat introduces carbonated protein drinks through its test kitchen as plant-based meat sales decline. Experts question whether the brand can successfully expand beyond meat alternatives.
JPMorgan Sees Strong AI Demand for CoreWeave
JPMorgan says CoreWeave’s AI demand remains very strong, driven by long-term contracts and limited compute supply, while keeping a Neutral rating.
Genmab's Epcoritamab Trial Falls Short on Key Survival Metric
Genmab's Phase 3 trial for epcoritamab shows mixed results in lymphoma patients, missing its overall survival goal despite some improvements.